Somatix gene therapy news

SOMA reduced its workforce to 105 from 130 employees in order to reduce the company's quarterly burn rate by $1 million to $4.5 million.

SOMA (Alameda, Calif.) also said it will create two business units focused on development and research. SOMA will remain focused on the clinical development of its GVAX cancer vaccine, gene therapy for Parkinson's disease, and the development of multiple gene transfer technologies. ...